Biotech Loan Interest: Floors, Fees and Payment Dates

Which financing cash flows belong in the runway scenario?

A loan headline gives a maximum facility size and an interest-only period. Neither tells you how much cash the company can spend today or when all debt cash payments begin. For a repeatable funding review, keep drawn principal, the interest formula, fees and principal repayment dates in separate fields.

The example below uses Rocket Pharmaceuticals' Form 8-K, accession 0001140361-26-038818, Item 1.01. The document is dated October 6, 2026 and describes a September 30, 2026 financing event. Those dates do not establish today's balance, rate or cash position. The SEC original was reviewed October 16, 2026.

Separate the facility limit from the scenario principal

The filing describes up to $150 million of term loans in tranches and a $35 million initial advance funded on the closing date. Later advances have their own availability periods and conditions. The facility ceiling is therefore not the amount on which this example assumes interest accrues.

Use a dated principal schedule. Record a later advance only with its supporting evidence, and preserve repayments or amendments rather than carrying a closing balance forward indefinitely. A disclosure that an advance was funded is also different from independently reconciling a bank receipt or the net cash available after fees.

In the worksheet below, $35 million held constant for a full year is an explicit illustration, not a claim about Rocket's subsequent outstanding balance or annual interest expense.

Read the floor before inserting a market rate

Item 1.01 states a floating annual formula of the greater of prime and 6.75%, plus 2.40%. Under that stated formula, 6.75% + 2.40% gives a 9.15% floor. This is a formula calculation, not a verified current coupon or an all-in borrowing cost.

Illustrative prime input	Formula rate	Simple annual interest on an assumed constant $35 million
6.00%, hypothetical	max(6.00%, 6.75%) + 2.40% = 9.15%	$3,202,500
7.75%, hypothetical	max(7.75%, 6.75%) + 2.40% = 10.15%	$3,552,500

The difference is $350,000 for that assumed principal and full-year exposure. Neither prime input is asserted to be the actual rate on a particular day. Do not divide these figures into an asserted monthly bill: actual balances, rate-reset dates, day-count conventions and payment provisions need their own evidence.

The filing also identifies facility and diligence fees and end-of-term charges. These calculations exclude fees, default-related changes and other financing cash flows. The net bank receipt and a complete effective borrowing cost remain UNKNOWN in this bounded example; the loan agreement is needed for a fuller calculation.

Keep three payment clocks separate

The same filing gives distinct normal-course dates and conditional extensions:

Clock in the disclosed terms	What the date describes	What it does not establish
Interest-only through April 1, 2029	Period before scheduled principal amortization under the stated terms	An absence of interest or fees
Possible later interest-only dates	Extensions tied to specified milestones and continuing conditions	Proof those milestones have occurred
Maturity October 1, 2030, with a conditional October 1, 2031 extension	Stated final maturity framework	A guaranteed extension or the absence of earlier principal payments

The filing describes monthly principal-and-interest installments after the applicable interest-only period. Reconcile that schedule with the actual agreement before building a dated cash forecast. Keep milestones, amendments and any default-related acceleration as separate evidence; a calendar date alone does not prove the current payment obligation.

Use a financing bridge without double counting

When comparing an earnings update with this financing, ask:

1. What cash balance and reporting date anchor the scenario?
2. Which completed financing flows occurred after that balance date?
3. What principal, rates and fees apply during the forecast interval?
4. Does the operating cash-use measure already include any modeled interest payments?
5. Which milestone or repayment changes the next dated cash requirement?

Do not add a separate interest forecast to a cash-use figure that already includes the same payment without reconciling the overlap. Missing disclosure leaves the adjustment UNKNOWN. This is an accounting check, not a prediction of a financing transaction, runway length or share-price response.

Use the cash-runway worksheet, SEC filing evidence map and going-concern guide to preserve balance dates and source scope. The existing article task prepares a general valuation-assumptions question for a company you select. Review that question and the required credits before a manual run; this dated illustration is not automatically loaded as current company evidence.